DLG4 and Parkinson disease: Treating PD mice with PF, SP600125, and PF+SP600125, significantly enhanced the protein levels of PSD95 and SYN, relative to untreated PD mice (PSD95: p = <0.05, <0.05, <0.01; SYN: all p = <0.01).